The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
The company is relieving all its staff who were directly engaged by our US subsidiary in its plant in connection with the manufacturing process in a phased manner
The round also saw participation from US-based fund 57 Stars, a few prominent angel investors, existing investors Stellaris Venture Partners, Vertex Ventures, and Alteria Capital
Subscribe To Our Newsletter & Stay Updated
